Intech Investment Management LLC Uro Gen Pharma Ltd. Transaction History
Intech Investment Management LLC
- $10 Billion
- Q4 2024
A detailed history of Intech Investment Management LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Intech Investment Management LLC holds 23,989 shares of URGN stock, worth $228,135. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,989
Previous 12,203
96.58%
Holding current value
$228,135
Previous $154,000
65.58%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding URGN
# of Institutions
137Shares Held
36.2MCall Options Held
57.7KPut Options Held
9.8K-
Rtw Investments, LP New York, NY3.83MShares$36.5 Million0.67% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.93MShares$27.8 Million0.06% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$21.9 Million0.15% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$20.9 Million0.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A61.75MShares$16.6 Million0.03% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $216M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...